SHAUN MYERS: Open Payments
NPI 1750983870 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 66 payments from 11 companies in 2025. Trend: 2023 $1,349 · 2024 $766 · 2025 $1,347
Food & beverage: $1,280Education: $67
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $330 |
| ABBVIE INC. | 15 | $219 |
| JAZZ PHARMACEUTICALS INC. | 7 | $198 |
| Vanda Pharmaceuticals Inc. | 8 | $170 |
| Axsome Therapeutics, Inc. | 8 | $162 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Corium, LLC | 2 | $62 |
| Lundbeck LLC | 2 | $41 |
| Alkermes, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: CAPLYTA, XYWAV, VRAYLAR, FANAPT, Auvelity, REXULTI, Azstarys, UBRELVY.
Industry payments across FL — which companies pay providers there.
